Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection.

Kril I, Zubchenko S, Havrylyuk A, Lomikovska M, Kuzan A, Jaskuła E, Chopyak V, Gamian A

Open source

DOI
10.1007/s12026-025-09741-3
Published
2026 Feb 17
Container
Immunologic research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12026-025-09741-3,
  title = {Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection.},
  author = {Kril I and Zubchenko S and Havrylyuk A and Lomikovska M and Kuzan A and Jaskuła E and Chopyak V and Gamian A},
  year = {2026},
  journal = {Immunologic research},
  doi = {10.1007/s12026-025-09741-3},
  url = {https://doi.org/10.1007/s12026-025-09741-3}
}

RIS

TY  - JOUR
TI  - Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection.
AU  - Kril I
AU  - Zubchenko S
AU  - Havrylyuk A
AU  - Lomikovska M
AU  - Kuzan A
AU  - Jaskuła E
AU  - Chopyak V
AU  - Gamian A
PY  - 2026
JO  - Immunologic research
DO  - 10.1007/s12026-025-09741-3
UR  - https://doi.org/10.1007/s12026-025-09741-3
ER  - 

APA

I, K., S, Z., A, H., M, L., A, K., E, J., V, C., & A, G. (2026). Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection.. Immunologic research. https://doi.org/10.1007/s12026-025-09741-3

Source records